Greve, Gabriele
Andrieux, Geoffroy http://orcid.org/0000-0002-5389-9481
Schlosser, Pascal http://orcid.org/0000-0002-8460-0462
Blagitko-Dorfs, Nadja
Rehman, Usama-Ur
Ma, Tobias
Pfeifer, Dietmar
Heil, Gerhard
Neubauer, Andreas
Krauter, Jürgen
Heuser, Michael http://orcid.org/0000-0001-5318-9044
Salih, Helmut R.
Döhner, Konstanze http://orcid.org/0000-0002-2261-9862
Döhner, Hartmut http://orcid.org/0000-0003-2116-5536
Hackanson, Björn http://orcid.org/0000-0001-7242-7503
Boerries, Melanie
Lübbert, Michael http://orcid.org/0000-0003-1186-1650
Article History
Received: 18 October 2022
Revised: 8 March 2023
Accepted: 13 March 2023
First Online: 6 April 2023
Competing interests
: MH <i>Honoraria:</i> Abbvie, Eurocept, Jazz Pharmaceuticals, Janssen, Novartis, Takeda. <i>Consultancy</i>: Abbvie, Agios, BMS, Daiichi Sankyo, Glycostem, Jazz Pharmaceuticals, Kura Oncology, Novartis, Pfizer, PinotBio, Roche, Tolremo <i>Research Funding for Institution</i>: Abbvie, Agios, Astellas, Bayer Pharma AG, BergenBio, Daiichi Sankyo, Glycostem, Jazz Pharmaceuticals, Loxo Oncology, Novartis, Pfizer, PinotBio, Roche. KD <i>Honoraria:</i> Novartis, Janssen, Jazz Pharmaceuticals, Celgene/BMS, Daiichi Sankyo, Roche. <i>Consultancy:</i> CTI BioPharma, Novartis, Janssen, Jazz Pharmaceuticals, Celgene/BMS, Daiichi Sankyo, Roche, Abbvie <i>Research Funding for Institution:</i> Novartis, Celgene/BMS, Astellas, Agios. HD <i>Honoraria:</i> AbbVie, Agios, Amgen, Astellas, AstraZeneca, BMS, Jazz Pharmaceuticals, Novartis, Daiichi Sankyo, Gilead, Janssen, Servier, Syndax. <i>Consultancy:</i> AbbVie, Agios, Amgen, Astellas, Berlin-Chemie, BMS, Jazz Pharmaceuticals, Novartis, Daiichi Sankyo, Gilead, Janssen, Servier, Syndax. <i>Research Funding:</i> AbbVie, Agios, Amgen, Astellas, Berlin-Chemie, BMS, Jazz Pharmaceuticals, Novartis, Kronos Bio, Pfizer. BH <i>Honoraria</i>: Roche, Boehringer Ingelheim, MSD, Bristol-Myers Squibb, Pfizer. <i>Research Funding:</i> Boehringer Ingelheim. <i>Travel, Accommodations, Expenses</i>: Novartis, Bristol-Myers Squibb. ML <i>Research Funding:</i> Janssen. <i>Consultancy:</i> Janssen. <i>Study Drug:</i> Cheplapharm, TEVA. All other authors declare no potential conflicts of interest.